DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB06268
| null |
Sitaxentan
|
184036-34-8
|
J9QH779MEM
|
Sitaxentan | Sitaxsentan
|
PHWXUGHIIBDVKD-UHFFFAOYSA-N
|
DB06270
| null |
MAHDL01
| null | null | null | null |
DB06271
| null |
Sulodexide
|
57821-29-1
|
75HGV0062C
|
Sulodexida | Sulodexide
| null |
DB06272
| null |
Maxacalcitol
|
103909-75-7
|
N2UJM5NBF6
|
Maxacalcitol
|
DTXXSJZBSTYZKE-ZDQKKZTESA-N
|
DB06273
| null |
Tocilizumab
|
375823-41-9
|
I031V2H011
|
Atlizumab | Tocilizumab
| null |
DB06274
| null |
Alvimopan
|
156053-89-3
|
Q153V49P3Z
|
Alvimopan | Alvimopan anhydrous | Anhydrous alvimopan
|
UPNUIXSCZBYVBB-JVFUWBCBSA-N
|
DB06276
| null |
Tanomastat
|
179545-77-8
|
AM1ZX94EXH
|
Tanomastat
|
JXAGDPXECXQWBC-LJQANCHMSA-N
|
DB06280
| null |
Senicapoc
|
289656-45-7
|
TS6G201A6Q
|
2,2-Bis(4-fluorophenyl)-2-phenylacetamide | Bis(4-fluorophenyl)phenylacetamide | Senicapoc
|
SCTZUZTYRMOMKT-UHFFFAOYSA-N
|
DB06281
| null |
Torcetrapib
|
262352-17-0
|
4N4457MV2U
|
Torcetrapib
|
CMSGWTNRGKRWGS-NQIIRXRSSA-N
|
DB06282
| null |
Levocetirizine
|
130018-77-8
|
6U5EA9RT2O
|
2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid | Levocetirizina | Levocetirizine
|
ZKLPARSLTMPFCP-OAQYLSRUSA-N
|
DB06283
| null |
Ziconotide
|
107452-89-1
|
7I64C51O16
|
Ziconotida | Ziconotide
| null |
DB06285
|
DB05581
|
Teriparatide
|
52232-67-4
|
10T9CSU89I
|
PTH (1-34) | PTH 1-34 | Teriparatida | Teriparatide | Teriparatide recombinant human
| null |
DB06287
| null |
Temsirolimus
|
162635-04-3
|
624KN6GM2T
|
Temsirolimus
|
CBPNZQVSJQDFBE-FUXHJELOSA-N
|
DB06288
| null |
Amisulpride
|
71675-85-9
|
8110R61I4U
|
4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide | 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide | Aminosultopride | Amisulprida | Amisulpride | Amisulpridum
|
NTJOBXMMWNYJFB-UHFFFAOYSA-N
|
DB06290
| null |
Simeprevir
|
923604-59-5
|
9WS5RD66HZ
|
Simeprevir
|
JTZZSQYMACOLNN-VDWJNHBNSA-N
|
DB06292
| null |
Dapagliflozin
|
461432-26-8
|
1ULL0QJ8UC
|
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | Dapagliflozin | Dapagliflozina
|
JVHXJTBJCFBINQ-ADAARDCZSA-N
|
DB06293
| null |
Pegnivacogin
|
959716-28-0
|
AYC3D1NPYB
|
Pegnivacogin
|
QGVYYLZOAMMKAH-UHFFFAOYSA-N
|
DB06294
| null |
Semuloparin
| null |
4QW4AN84NQ
|
Octaparin | Octaparine | Semuloparin
| null |
DB06295
| null |
Pramiconazole
|
219923-85-0
|
4SYH0R661F
|
Pramiconazole
|
AEKNYBWUEYNWMJ-QWOOXDRHSA-N
|
DB06297
| null |
LX-2931
|
948840-25-3
|
C5AGI979T7
| null |
AMXVYJYMZLDINS-RSWLNLDNSA-N
|
DB06299
| null |
Hydronidone
|
851518-71-3
|
RXQ128313W
|
N-(4-Hydroxyphenyl)-5-methyl-2-pyridone
|
NETTXQJYJRFTFS-UHFFFAOYSA-N
|
DB06302
| null |
Glesatinib
|
936694-12-1
|
7Q29OXD98N
|
Glesatinib
|
YRCHYHRCBXNYNU-UHFFFAOYSA-N
|
DB06303
| null |
Otilimab
|
1638332-55-4
|
Y8127R3VCH
|
Otilimab
| null |
DB06304
| null |
BIIB015
| null | null |
Anti-Cripto-DM4
| null |
DB06305
| null |
Sonepcizumab
|
1031360-18-5
|
O4T5UXS4P2
| null | null |
DB06306
| null |
Onalespib
|
912999-49-6
|
Q7Y33N57ZZ
|
Onalespib
|
IFRGXKKQHBVPCQ-UHFFFAOYSA-N
|
DB06307
| null |
Apoptone
|
183387-50-0
|
891O182ZP5
| null |
CKAXZOYFIHQCBN-JRRMKBMNSA-N
|
DB06308
| null |
NP2
| null | null | null | null |
DB06309
| null |
Refametinib
|
923032-37-5
|
JPX07AFM0N
|
Refametinib
|
RDSACQWTXKSHJT-NSHDSACASA-N
|
DB06310
| null |
Motavizumab
|
677010-34-3
|
50Y163LK8Q
|
Motavizumab
| null |
DB06311
| null |
Darapladib
|
356057-34-6
|
UI1U1MYH09
|
Darapladib
|
WDPFJWLDPVQCAJ-UHFFFAOYSA-N
|
DB06313
| null |
BNC105
|
945772-45-2
|
TO9V2XZF53
| null |
MYDHDVLPMRNDAZ-UHFFFAOYSA-N
|
DB06314
|
DB08584
|
SGX-523
|
1022150-57-7
|
WH8SQN09KJ
|
6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline
|
BCZUAADEACICHN-UHFFFAOYSA-N
|
DB06315
| null |
ISF402
|
484649-95-8
| null | null |
BYWLSTFTCYEFLE-GIEZYDSUSA-N
|
DB06316
| null |
R343
|
575484-78-5
|
Y4069R7J86
|
2- {3- [4-(2,2-Difluoro-3 -oxo-3,4-dihydro-2H-benzo [1,4] oxazin-6-ylamino)5-fluoro-pyrimidin-2-ylamino]phenoxy}N-methyl-acetamide
|
MOXXQFNQDDSJHT-UHFFFAOYSA-N
|
DB06317
| null |
Elotuzumab
|
915296-00-3
|
1351PE5UGS
|
Elotuzumab | HuLuc63 | Immunoglobulin G1, anti-(human protein CS1) (human-mouse HuLuc63 heavy chain), disulfide with human-mouse HuLuc63 kappa-chain, dimer
| null |
DB06318
| null |
AVE9633
| null | null |
huMy9-6-DM4
| null |
DB06319
| null |
XP21279
| null | null | null | null |
DB06321
| null |
R-348
|
916742-11-5
|
3J396119JY
|
5-Fluoro-N-(4-methyl-3-propionylaminosulfonylphenyl)-N'-(4-(prop-2-ynyloxy)phenyl)-2,4-pyrimidinediamine
|
IGLNXKVGKIFNBQ-UHFFFAOYSA-N
|
DB06322
| null |
Carotuximab
|
1268714-50-6
|
YB2EWE6139
|
Carotuximab | Chimeric anti-CD105 antibody | GAMMA1 HEAVY CHAIN (1-448) (MUS MUSCULUS VH (IGHV6-6*01-(IGHD) -IGHJ2*01) (8.10.9) (1-118) -HOMO SAPIENSIGHG1*01, GM17,1 (CH1 (119-216), HINGE (217-231), CH2(232-341), CH3 (342-446), CHS (447-448)) (119-448)), (221-213')-DISULFIDE WITH KAPPA LIGHT CHAIN | IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN ENDOGLIN (CD105 ANTIGEN)) HUMAN MOUSE CHIMERIC MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-448) (MOUSE VH (MUS MUSCULUS IGHV6-6*01 (98%) (IGHD)-IGHJ2*01 (87%)) (8.10.9) (1-118) -HOMO SAPIENS IGHG1*01 (119-448)) (221-2 | IMMUNOGLOBULIN G1, ANTI-(HUMAN ENDOGLIN) (HUMAN-MUS MUSCULUS MONOCLONAL TRC105 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TRC105 .KAPPA.-CHAIN, DIMER
| null |
DB06323
| null |
AZX-100
|
1217194-46-1
|
0HT093MD6R
| null | null |
DB06324
| null |
XmAb 2513
| null |
33VWC847G8
| null | null |
DB06325
| null |
Pegpleranib
|
1618657-13-8
|
VER541H6NK
|
Pegpleranib
| null |
DB06326
| null |
Latiglutenase
|
1360452-96-5
|
090PL12YZJ
|
Latiglutenase
| null |
DB06328
| null |
Methoxyamine
|
67-62-9
|
9TZH4WY30J
| null |
GMPKIPWJBDOURN-UHFFFAOYSA-N
|
DB06329
| null |
RG-7795
|
892498-64-5
|
QTI86134YL
| null |
HOOMGTNENMZAFP-NYNCVSEMSA-N
|
DB06331
| null |
4-O-Demethylpenclomedine
|
176046-79-0
|
XUK71J2M0Q
|
4-Demethylpenclomedine | 4-Dm-pen | 4-Dmpen | DM-PEN | DMPEN
|
GUYGGZGIKZIRFO-UHFFFAOYSA-N
|
DB06333
| null |
Trodusquemine
|
186139-09-3
|
KKC12PIF16
|
Trodusquemine
|
WUJVPODXELZABP-FWJXURDUSA-N
|
DB06334
| null |
Tucidinostat
|
1616493-44-7
|
87CIC980Y0
|
Chidamide | Tucidinostat
|
SZMJVTADHFNAIS-BJMVGYQFSA-N
|
DB06335
| null |
Saxagliptin
|
361442-04-8
|
8I7IO46IVQ
|
(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile | Saxagliptin | Saxagliptin anhydrous | Saxagliptina
|
QGJUIPDUBHWZPV-SGTAVMJGSA-N
|
DB06336
| null |
Elsiglutide
|
914009-84-0
|
SC864Q40VB
|
Elsiglutide
| null |
DB06338
| null |
ARG098
| null | null | null | null |
DB06342
| null |
Coltuximab ravtansine
|
1269764-99-9
|
MRS84YT9L2
|
Anti-CD19 humanized monoclonal antibody conjugated to DM4 | Coltuximab ravtansine
| null |
DB06343
| null |
Teprotumumab
|
1036734-93-6
|
Y64GQ0KC0A
|
Immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human monoclonal heavy chain), disulfide with human monoclonal light chain, dimer | Teprotumumab | teprotumumab-trbw
| null |
DB06345
| null |
AR-9281
|
913548-29-5
|
4HA03Q8EZ9
|
APAU
|
HUDQLWBKJOMXSZ-UHFFFAOYSA-N
|
DB06346
| null |
Fiboflapon
|
936350-00-4
|
Y1NA96IX3T
|
Fiboflapon
|
DFQGDHBGRSTTHX-UHFFFAOYSA-N
|
DB06347
| null |
Cenisertib
|
871357-89-0
|
5277GPA358
|
Cenisertib
|
KSOVGRCOLZZTPF-QMKUDKLTSA-N
|
DB06349
| null |
KB3305
|
639520-46-0
|
7Q26YN85LO
|
(4R)-4-((3S,5R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-DIHYDROXY-3-(2-(4-((8S,11R,13S,14S,17S)-17-HYDROXY-13-METHYL-3-OXO-17-PROP-1-YNYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA(A)PHENANTHREN-11-YL)-N-METHYL-ANILINO)ETHOXY)-10,13-DIMETHYL-2,3,4,5,6,7,8,9, | 3.BETA.,5.BETA.,7.ALPHA.,12.ALPHA.)-7,12-DIHYDROXY-3-(2-((4-((11.BETA.,17.BETA.)-17-HYDROXY-3-OXO-17-(1-PROPYN-1-YL)ESTRA-4,9-DIEN-11-YL)PHENYL)METHYLAMINO)ETHOXY)CHOLAN-24-OIC ACID | CHOLAN-24-OIC ACID, 7,12-DIHYDROXY-3-(2-((4-((11.BETA.,17.BETA.)-17-HYDROXY-3-OXO-17-(1-PROPYN-1-YL)ESTRA-4,9-DIEN-11-YL)PHENYL)METHYLAMINO)ETHOXY)-, (3.BETA.,5.BETA.,7.ALPHA.,12.ALPHA.)-
|
LEUWECPXLBIBOF-LXEVTIFISA-N
|
DB06350
| null |
Elinogrel
|
936500-94-6
|
915Y8E749J
|
Elinogrel
|
LGSDFTPAICUONK-UHFFFAOYSA-N
|
DB06351
| null |
SPC2968
| null | null | null | null |
DB06352
| null |
Butyrylcholinesterase
|
9001-08-5
|
1M8W6DVG0L
|
Acylcholine acylhydrolase | BChE | BuChE | Butyrylcholine esterase | Choline esterase | Propionylcholinesterase | Pseudocholinesterase
| null |
DB06354
| null |
Tezampanel
|
154652-83-2
|
GA36S2O9C2
|
Tezampanel | Tezampanel (anhydrous) | Tezampanel, anhydrous
|
ZXFRFPSZAKNPQQ-YTWAJWBKSA-N
|
DB06355
| null |
ACY001
| null | null |
Adult-derived hemangioblast stem cells
| null |
DB06356
| null |
TRC093
| null | null | null | null |
DB06358
| null |
Iclaprim
|
192314-93-5
|
42445HUU0O
|
Iclaprim
|
HWJPWWYTGBZDEG-UHFFFAOYSA-N
|
DB06359
| null |
G4460
| null | null |
c-myb antisense oligodeoxynucleotide | c-myb antisense oligonucleotide G4460
| null |
DB06360
| null |
Lucatumumab
|
903512-50-5
|
P0EP9VFC4R
|
Lucatumumab | Recombinant anti-CD40 monoclonal antibody
| null |
DB06361
| null |
rsPSMA Vaccine
| null | null |
Recombinant soluble prostate-specific membrane antigen (rsPSMA) vaccine | rsPSMA
| null |
DB06362
| null |
Becatecarin
|
119673-08-4
|
A60X6MBU6G
|
6-(2-(DIETHYLAMINO)ETHYL)-REBECCAMYCIN | Becatecarin | DEAE-rebeccamycin
|
JSKFWUPVIZYJMR-UDOAKELVSA-N
|
DB06363
| null |
TGAAC09
| null | null |
AAV-2 HIV Vaccine
| null |
DB06364
| null |
XR5944
|
343247-32-5
|
LJH9XG66Q9
| null |
SFOADSRLCHRTKT-UHFFFAOYSA-N
|
DB06365
| null |
Sapacitabine
|
151823-14-2
|
W335P73C3L
|
1-(2-C-cyano-2-deoxy- ß-D-arabino-pentafuranosyl)-N4-palmitoylcytosine | Sapacitabine
|
LBGFKUUHOPIEMA-PEARBKPGSA-N
|
DB06366
| null |
Pertuzumab
|
380610-27-5
|
K16AIQ8CTM
|
2C4 Antibody | MOAB 2C4 | Monoclonal Antibody 2C4 | Pertuzumab | rhuMAb-2C4
| null |
DB06367
| null |
Relacatib
|
362505-84-8
|
BL51M8CB8R
|
Relacatib
|
BWYBBMQLUKXECQ-GIVPXCGWSA-N
|
DB06368
| null |
Alamifovir
|
193681-12-8
|
0N739K2A8A
|
Alamifovir
|
VDBGPMJFHCJMOL-UHFFFAOYSA-N
|
DB06370
| null |
Indisulam
|
165668-41-7
|
WJ98J3NM90
|
Indisulam
|
SETFNECMODOHTO-UHFFFAOYSA-N
|
DB06371
| null |
Siplizumab
|
288392-69-8
|
KUW1QG1ZM3
|
Siplizumab
| null |
DB06372
| null |
Rilonacept
|
501081-76-1
|
8K80YB5GMG
|
IL-1 TRAP | IL-1-TRAP | interleukin-1 (IL-1) trap | Rilonacept
| null |
DB06373
| null |
ASI402
|
372075-37-1
|
3VD89OE565
|
Epitumomab | IMMUNOGLOBULIN G1, ANTI-(HUMAN EPISIALIN) (HUMAN-MOUSE MONOCLONAL HMFG-1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HMFG-1, DIMER | IMMUNOGLOBULIN G1, ANTI-(HUMAN EPISIALIN) (MOUSE MONOCLONAL HMFG-1 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL HMFG-1, DIMER | SONTUZUMAB
| null |
DB06374
| null |
Elacestrant
|
722533-56-4
|
FM6A2627A8
|
(2R)-2-(2-(ethyl-((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxy-phenyl)tetralin-6-ol | (6R)-6-(2-(ethyl((4-(2- (ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)- 5,6,7,8-tetrahydronaphthalen-2-ol | 2-naphthalenol, 6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-, (6R)- | Elacestrant
|
SIFNOOUKXBRGGB-AREMUKBSSA-N
|
DB06375
| null |
MD05
| null | null | null | null |
DB06376
| null |
CHGN111
| null | null | null | null |
DB06379
|
DB05621
|
Calcitonin gene-related peptide
|
83652-28-2
|
JHB2QIZ69Z
|
Calcitonin gene related peptide | Calcitonin-gene-related peptide | CGRP | LAB CGRP
| null |
DB06382
| null |
CY301
| null | null | null | null |
DB06383
| null |
NRP290
| null | null | null | null |
DB06384
| null |
NRP369
| null | null | null | null |
DB06388
| null |
AOD9604
|
221231-10-3
|
7UP768IP4M
|
L-PHENYLALANINE, L-TYROSYL-L-LEUCYL-L-ARGINYL-L-ISOLEUCYL-L-VALYL-L-GLUTAMINYL-L-CYSTEINYL-L-ARGINYL-L-SERYL-L-VALYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-SERYL-L-CYSTEINYLGLYCYL-, CYCLIC (7->14)-DISULFIDE | TYR-LEU-ARG-ILE-VAL-GLN-CYS-ARG-SER-VAL-GLU-GLY-SER-CYS-GLY-PHE CYCLIC (7->14)-DISULFIDE
|
GVIYUKXRXPXMQM-BPXGDYAESA-N
|
DB06390
| null |
APT3111
| null | null |
APT 2392 | CD59-Prodaptin
| null |
DB06391
| null |
T611
|
350595-61-8
|
YJN0IQX3S4
|
2-(3S-3-METHYLMORPHOLINO)-4-(IMIDAZOL-1-YL)-6-METHYL-5-NITROPYRIMIDINE BENZENESULFONATE | BENZENESULFONIC ACID; (3S)-4-(4-IMIDAZOL-1-YL-6-METHYL-5-NITRO-PYRIMIDIN-2-YL)-3-METHYL-MORPHOLINE | MORPHOLINE, 4-(4-(1H-IMIDAZOL-1-YL)-6-METHYL-5-NITRO-2-PYRIMIDINYL)-3-METHYL-, (3S)-, BENZENESULFONATE (1:1)
|
GPJYNQNPOAOBPJ-FVGYRXGTSA-N
|
DB06393
| null |
Xaliproden
|
135354-02-8
|
V8QL94KNQO
|
Xaliproden
|
WJJYZXPHLSLMGE-UHFFFAOYSA-N
|
DB06394
| null |
Riferminogene pecaplasmid
|
1001859-46-6
|
3G30P7ME1J
|
Non-viral fibroblast growth factor 1 | NV1FGF | Riferminogene pecaplasmid
| null |
DB06395
| null |
Abafungin
|
129639-79-8
|
11DI31LWXF
|
Abafungin | Abafungina | Abafungine | Abafunginum
|
TYBHXIFFPVFXQW-UHFFFAOYSA-N
|
DB06397
| null |
Nicaraven
|
79455-30-4
|
UD8PEV6JBD
| null |
KTXBOOWDLPUROC-UHFFFAOYSA-N
|
DB06399
| null |
Atacicept
|
845264-92-8
|
K3D9A0ICQ3
|
Atacicept | Human Transmembrane Activator and CAML Interactor (TACI) Immunoglobulin G1 Fc Domain Fusion Protein (Fc5) | TACI-Fc5 | TACI-IG
| null |
DB06400
| null |
Vitespen
|
492448-75-6
|
H3598Y1TLJ
|
Endoplasmin (human tumor rejection antigen 1) | Heat shock protein-peptide complex-96 vaccine | Oncophage | Vitespen
| null |
DB06401
| null |
Bazedoxifene
|
198481-32-2
|
Q16TT9C5BK
|
Bazedoxifene | Bazedoxifeno
|
UCJGJABZCDBEDK-UHFFFAOYSA-N
|
DB06402
| null |
Telavancin
|
372151-71-8
|
XK134822Z0
|
Telavancin | Telavancina | Télavancine | Telavancinum
|
ONUMZHGUFYIKPM-MXNFEBESSA-N
|
DB06403
| null |
Ambrisentan
|
177036-94-1
|
HW6NV07QEC
|
(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid | Ambrisentan
|
OUJTZYPIHDYQMC-LJQANCHMSA-N
|
DB06404
|
DB05341
|
Human C1-esterase inhibitor
| null |
6KIC4BB60G
|
C1 Esterase Inhibitor (Human) | C1 inhibitor | C1 inhibitor (human) | C1 inhibitor human | C1-esterase inhibitor, human | C1-INH | C1-inhibiting factor | C1-inhibitor, plasma derived | Human C1 inhibitor | Human C1-esterase inhibitor | Plasma protease C1 inhibitor
| null |
DB06405
| null |
Eprodisate
|
21668-77-9
|
6QFP76V7S7
|
1,3-propanedisulfonic acid | Eprodisate | Propane-1,3-disulfonate | Propane-1,3-disulfonic acid | Propane-1,3-disulphonate
|
MGNVWUDMMXZUDI-UHFFFAOYSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.